2025-05-02 11:20:31
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Alembic Pharmaceuticals Ltd Q4 FY2020 consolidated net profit at Rs. 203.45 crore
Posted On : 2020-05-22 14:29:25( TIMEZONE : IST )
ALEMBIC PHARMACEUTICALS LTD. has reported financial results for the period ended March 31, 2020.
Financial Results (Q4 FY19-20) - QoQ Comparison
The company has reported total income of Rs.1207.72 crores during the period ended March 31, 2020 as compared to Rs.1209.54 crores during the period ended December 31, 2019.
The company has posted net profit / (loss) of Rs.203.45 crores for the period ended March 31, 2020 as against net profit / (loss) of Rs.227.31 crores for the period ended December 31, 2019.
The company has reported EPS of Rs.11.92 for the period ended March 31, 2020 as compared to Rs.12.42 for the period ended December 31, 2019.
| Financials | Q4 FY19-20 | Q3 FY19-20 | % Change |
| Total Income | ₹ 1207.72 crs | ₹ 1209.54 crs |  -0.15% |
| Net Profit | ₹ 203.45 crs | ₹ 227.31 crs | -10.5% |
| EPS | ₹ 11.92 | ₹ 12.42 | -4.03% |
Financial Results (Q4 FY19-20) - YoY Comparison
The company has reported total income of Rs.1207.72 crores during the period ended March 31, 2020 as compared to Rs.930.32 crores during the period ended March 31, 2019.
The company has posted net profit / (loss) of Rs.203.45 crores for the period ended March 31, 2020 as against net profit / (loss) of Rs.123.70 crores for the period ended March 31, 2019.
The company has reported EPS of Rs.11.92 for the period ended March 31, 2020 as compared to Rs.6.58 for the period ended March 31, 2019.
| Financials | Q4 FY19-20 | Q4 FY18-19 | % Change |
| Total Income | ₹ 1207.72 crs | ₹ 930.32 crs |  29.82% |
| Net Profit | ₹ 203.45 crs | ₹ 123.70 crs | 64.47% |
| EPS | ₹ 11.92 | ₹ 6.58 | 81.16% |
Financial Results (12 months ended FY 19-20) - YoY Comparison
The company has reported total income of Rs.4610.69 crores during the 12 months period ended March 31, 2020 as compared to Rs.3944.06 crores during the 12 months period ended March 31, 2019.
The company has posted net profit / (loss) of Rs.800.70 crores for the 12 months period ended March 31, 2020 as against net profit / (loss) of Rs.583.29 crores for the 12 months period ended March 31, 2019.
The company has reported EPS of Rs.43.97 for the 12 months period ended March 31, 2020 as compared to Rs.31 for the 12 months period ended March 31, 2019.
| Financials | Year Ended FY19-20 | Year Ended FY18-19 | % Change |
| Total Income | ₹ 4610.69 crs | ₹ 3944.06 crs | 16.9% |
| Net Profit | ₹ 800.70 crs | ₹ 583.29 crs | 37.27% |
| EPS | ₹ 43.97 | ₹31 | 41.84% |
Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs.897.65 as compared to the previous close of Rs. 870.9. The total number of shares traded during the day was 17319 in over 1323 trades.
The stock hit an intraday high of Rs. 910.15 and intraday low of 860. The net turnover during the day was Rs. 15362906.
